Finance

Lists
Why is 600993 up 3,54%?
Dive Deeper
600993:SHA
Mayinglong Pharmaceutical Group Co Ltd
CNÂ¥24,56
+3,54%
(+0,84) 1D
14 Okt., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600993...
Open
CNÂ¥23,62
High
CNÂ¥24,65
Low
CNÂ¥23,60
Mkt. cap
10,17 mjd
Avg. vol.
3,55 m
Volume
11,59 m
Dividend
2,85%
Quarterly dividend
CNÂ¥0,18
Ex-dividend date
05 Aug. 2026
P/E ratio
17,62
52-wk high
CNÂ¥30,18
52-wk low
CNÂ¥21,22
EPS
CNÂ¥1,39
Shares outstanding
431,05 m
No. of employees
3 k
Open
CNÂ¥23,62
High
CNÂ¥24,65
Low
CNÂ¥23,60
Mkt. cap
10,17 mjd
Avg. vol.
3,55 m
Volume
11,59 m
Dividend
2,85%
Quarterly dividend
CNÂ¥0,18
Ex-dividend date
05 Aug. 2026
P/E ratio
17,62
52-wk high
CNÂ¥30,18
52-wk low
CNÂ¥21,22
EPS
CNÂ¥1,39
Shares outstanding
431,05 m
No. of employees
3 k
News stories
From web sources and news partners
About Mayinglong Pharmaceutical Group Co Ltd
CEO-
Employees2,54 k
Founded1582
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
888,26 m
1,03 mjd
1,01 mjd
999,38 m
Cost of goods sold
460,66 m
521,28 m
524,38 m
546,24 m
Cost of revenue
460,66 m
521,28 m
524,38 m
546,24 m
Research and development expenses
20,83 m
19,99 m
17,06 m
14,68 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
232,34 m
392,42 m
219,69 m
256,36 m
Operating expense
252,95 m
423,97 m
243,25 m
288,91 m
Total operating expenses
713,61 m
945,24 m
767,64 m
835,15 m
Operating income
174,65 m
84,08 m
244,73 m
164,22 m
Other non operating income
6,84 m
2,12 m
-100,17 k
-1,47 m
EBT including unusual items
187,83 m
100,89 m
255,42 m
187,60 m
EBT excluding unusual items
200,49 m
110,29 m
253,57 m
169,52 m
Income tax expense
25,95 m
14,42 m
36,14 m
29,69 m
Effective tax rate
13,81%
14,30%
14,15%
15,83%
Other operating expenses
-8,32 m
20,94 m
4,28 m
9,21 m
Net income
157,79 m
80,48 m
212,59 m
150,03 m
Net profit margin
17,76%
7,82%
21,00%
15,01%
Earnings per share
-
-
-
-
Interest and investment income
20,70 m
26,15 m
10,03 m
7,77 m
Interest expense
-1,72 m
-2,19 m
-1,10 m
-994,32 k
Net interest expenses
18,99 m
23,96 m
8,94 m
6,77 m
Depreciation and amortization charges
-
-
-
-
EBITDA
185,56 m
98,76 m
259,41 m
176,98 m
Gain or loss from assets sale
-216,81 k
89,70 k
-
58,75 k
AI content may include mistakes. Learn more
Google-programme